HIV Gag p24 specific responses secreting IFN-γ and/or IL-2 in treatment-naïve individuals in acute infection early disease (AIED) are associated with low viral load

Michel L. Ndongala, Yoav Peretz, Salix Boulet, Mehrnoosh Doroudchi, Bader Yassine-Diab, Mohamed Rachid Boulassel, Danielle Rouleau, Cécile Tremblay, Roger LeBlanc, Jean Pierre Routy, Rafick Pierre Sékaly, Nicole F. Bernard

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

HIV-specific immune responses in acute infection early disease (AIED) may be effective at controlling viral replication and in establishing viral load (VL) set point. However, evidence correlating the function and specificity of these responses with the VL set point is lacking. To address this issue, we screened cells from 59 treatment-naïve HIV infected individuals (33 in AIED and 26 progressors) for responses to the entire HIV proteome using a dual color ELISPOT assay detecting 3 functional lymphocyte populations: single IFN-γ, dual IFN-γ/IL-2 and single IL-2 secreting cells. Responses characterized by dual secreting cells contributed more to the HIV specific response in AIED versus chronic infection. Of responses directed to individual HIV gene products the magnitude and breadth of only Gag p24-specific responses for the 3 functional subsets were associated with lower concurrent or set point VL. Therefore the early appearance of broader and more intense Gag-p24-specific responses may be a determinant of subsequent VL.

Original languageEnglish (US)
Pages (from-to)277-287
Number of pages11
JournalClinical Immunology
Volume131
Issue number2
DOIs
StatePublished - May 2009
Externally publishedYes

Fingerprint

HIV Core Protein p24
Viral Load
Interleukin-2
HIV
Infection
Human Immunodeficiency Virus Proteins
Enzyme-Linked Immunospot Assay
Proteome
Therapeutics
Chronic Disease
Color
Lymphocytes
Population

Keywords

  • AIED
  • Dual color ELISPOT
  • HIV Gag p24 responses
  • HIV viremia

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

HIV Gag p24 specific responses secreting IFN-γ and/or IL-2 in treatment-naïve individuals in acute infection early disease (AIED) are associated with low viral load. / Ndongala, Michel L.; Peretz, Yoav; Boulet, Salix; Doroudchi, Mehrnoosh; Yassine-Diab, Bader; Boulassel, Mohamed Rachid; Rouleau, Danielle; Tremblay, Cécile; LeBlanc, Roger; Routy, Jean Pierre; Sékaly, Rafick Pierre; Bernard, Nicole F.

In: Clinical Immunology, Vol. 131, No. 2, 05.2009, p. 277-287.

Research output: Contribution to journalArticle

Ndongala, ML, Peretz, Y, Boulet, S, Doroudchi, M, Yassine-Diab, B, Boulassel, MR, Rouleau, D, Tremblay, C, LeBlanc, R, Routy, JP, Sékaly, RP & Bernard, NF 2009, 'HIV Gag p24 specific responses secreting IFN-γ and/or IL-2 in treatment-naïve individuals in acute infection early disease (AIED) are associated with low viral load', Clinical Immunology, vol. 131, no. 2, pp. 277-287. https://doi.org/10.1016/j.clim.2008.11.006
Ndongala, Michel L. ; Peretz, Yoav ; Boulet, Salix ; Doroudchi, Mehrnoosh ; Yassine-Diab, Bader ; Boulassel, Mohamed Rachid ; Rouleau, Danielle ; Tremblay, Cécile ; LeBlanc, Roger ; Routy, Jean Pierre ; Sékaly, Rafick Pierre ; Bernard, Nicole F. / HIV Gag p24 specific responses secreting IFN-γ and/or IL-2 in treatment-naïve individuals in acute infection early disease (AIED) are associated with low viral load. In: Clinical Immunology. 2009 ; Vol. 131, No. 2. pp. 277-287.
@article{89004913a23c45328a7b505eea27068a,
title = "HIV Gag p24 specific responses secreting IFN-γ and/or IL-2 in treatment-na{\"i}ve individuals in acute infection early disease (AIED) are associated with low viral load",
abstract = "HIV-specific immune responses in acute infection early disease (AIED) may be effective at controlling viral replication and in establishing viral load (VL) set point. However, evidence correlating the function and specificity of these responses with the VL set point is lacking. To address this issue, we screened cells from 59 treatment-na{\"i}ve HIV infected individuals (33 in AIED and 26 progressors) for responses to the entire HIV proteome using a dual color ELISPOT assay detecting 3 functional lymphocyte populations: single IFN-γ, dual IFN-γ/IL-2 and single IL-2 secreting cells. Responses characterized by dual secreting cells contributed more to the HIV specific response in AIED versus chronic infection. Of responses directed to individual HIV gene products the magnitude and breadth of only Gag p24-specific responses for the 3 functional subsets were associated with lower concurrent or set point VL. Therefore the early appearance of broader and more intense Gag-p24-specific responses may be a determinant of subsequent VL.",
keywords = "AIED, Dual color ELISPOT, HIV Gag p24 responses, HIV viremia",
author = "Ndongala, {Michel L.} and Yoav Peretz and Salix Boulet and Mehrnoosh Doroudchi and Bader Yassine-Diab and Boulassel, {Mohamed Rachid} and Danielle Rouleau and C{\'e}cile Tremblay and Roger LeBlanc and Routy, {Jean Pierre} and S{\'e}kaly, {Rafick Pierre} and Bernard, {Nicole F.}",
year = "2009",
month = "5",
doi = "10.1016/j.clim.2008.11.006",
language = "English (US)",
volume = "131",
pages = "277--287",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - HIV Gag p24 specific responses secreting IFN-γ and/or IL-2 in treatment-naïve individuals in acute infection early disease (AIED) are associated with low viral load

AU - Ndongala, Michel L.

AU - Peretz, Yoav

AU - Boulet, Salix

AU - Doroudchi, Mehrnoosh

AU - Yassine-Diab, Bader

AU - Boulassel, Mohamed Rachid

AU - Rouleau, Danielle

AU - Tremblay, Cécile

AU - LeBlanc, Roger

AU - Routy, Jean Pierre

AU - Sékaly, Rafick Pierre

AU - Bernard, Nicole F.

PY - 2009/5

Y1 - 2009/5

N2 - HIV-specific immune responses in acute infection early disease (AIED) may be effective at controlling viral replication and in establishing viral load (VL) set point. However, evidence correlating the function and specificity of these responses with the VL set point is lacking. To address this issue, we screened cells from 59 treatment-naïve HIV infected individuals (33 in AIED and 26 progressors) for responses to the entire HIV proteome using a dual color ELISPOT assay detecting 3 functional lymphocyte populations: single IFN-γ, dual IFN-γ/IL-2 and single IL-2 secreting cells. Responses characterized by dual secreting cells contributed more to the HIV specific response in AIED versus chronic infection. Of responses directed to individual HIV gene products the magnitude and breadth of only Gag p24-specific responses for the 3 functional subsets were associated with lower concurrent or set point VL. Therefore the early appearance of broader and more intense Gag-p24-specific responses may be a determinant of subsequent VL.

AB - HIV-specific immune responses in acute infection early disease (AIED) may be effective at controlling viral replication and in establishing viral load (VL) set point. However, evidence correlating the function and specificity of these responses with the VL set point is lacking. To address this issue, we screened cells from 59 treatment-naïve HIV infected individuals (33 in AIED and 26 progressors) for responses to the entire HIV proteome using a dual color ELISPOT assay detecting 3 functional lymphocyte populations: single IFN-γ, dual IFN-γ/IL-2 and single IL-2 secreting cells. Responses characterized by dual secreting cells contributed more to the HIV specific response in AIED versus chronic infection. Of responses directed to individual HIV gene products the magnitude and breadth of only Gag p24-specific responses for the 3 functional subsets were associated with lower concurrent or set point VL. Therefore the early appearance of broader and more intense Gag-p24-specific responses may be a determinant of subsequent VL.

KW - AIED

KW - Dual color ELISPOT

KW - HIV Gag p24 responses

KW - HIV viremia

UR - http://www.scopus.com/inward/record.url?scp=63749103545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63749103545&partnerID=8YFLogxK

U2 - 10.1016/j.clim.2008.11.006

DO - 10.1016/j.clim.2008.11.006

M3 - Article

VL - 131

SP - 277

EP - 287

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 2

ER -